CRYGFP

Across TCGA pan-cancer cohorts, CRYGFP RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CRYGFP data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher CRYGFP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CRYGFP expression acts as an unfavorable survival marker.

LIHC, COAD, and ESCA are the cancer types where CRYGFP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.182	0.695	<.001	108	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
ESCA	OS	Tertile	II,III,IV	0.103	0.868	<.001	36	view →
SKCM	OS	Tertile	All	0.465	0.787	.002	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	18	view →
PRAD	OS	Tertile	All	0.817	0.890	<.001	18	view →
THCA	DFS	Tertile	II,III,IV	0.145	0.794	.001	18	view →
STAD	DFS	Tertile	All	0.534	0.672	.027	9	view →
CHOL	OS	Tertile	All	0.247	0.678	.013	9	view →
ACC	DFS	Tertile	All	0.143	0.594	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

CRYGFP–LIHC (OS)

Open the LIHC breakdown →